Search clinical trials for: Methotrexate, Hydroxychloroquine

Total 1905 results

Children's Hospital of Fudan University

Recruiting

Hydroxychloroquin (HCQ) in chILD of Genetic Defect

Surfactant Dysfunction

China
Radboud University Medical Center

Unknown

Autophagy Inhibition Using Hydrochloroquine in Breast Cancer Patients

Breast Cancer

Netherlands
Cambridge University Hospitals NHS Foundation Trust

Unknown

PROLIFIC ChemoprophylaxisTrial (COVID-19)

COVID-19

United Kingdom
Alkarkh Health Directorate-Baghdad

Completed

Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients

IMMUNOTHERAPY

Iraq
Sanjay Gandhi Postgraduate Institute of Medical...

Completed

Combination Disease-Modifying Antirheumatic Drugs (DMARDs) Versus Sulfasalazine in Inflammatory Back Pain

Seronegative Spondyloarthropathies

India
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Withdrawn

CPI-613 and Hydroxychloroquine for Patients With High Risk Myelodysplastic Syndrome

Myelodysplastic Syndromes | Progressive Disease

United States
Health Institutes of Turkey

Completed

Clinical Trial For Early SARS-CoV-2 (COVID-19) Treatment

Covid19

Turkey
University Hospital, Strasbourg, France

Recruiting

Clinical Trial Evaluating Methotrexate or Leflunomide + Targeted Therapy Versus Methotrexate or Leflunomide + Sulfasalazine + Hydroxychloroquine in Patients With Rheumatoid Arthritis and Insufficient Response to Methotrexate or Leflunomide (BIO3)

Rheumatoid Arthritis | Insufficient Response to Methotrexate or Leflunomide

France
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Etanercept With Usual DMARD Therapy in Subjects With Rheumatoid Arthritis in the Asia Pacific Region

Rheumatoid Arthritis

Hong Kong, Philippines, Taiwan, Thailand, India, Korea, Republic of, Malaysia, Singapore
University of Nebraska

Completed

Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations in the Treatment of Rheumatoid Arthritis

Rheumatoid Arthritis

United States
Peng Wang, MD PhD

Completed

HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors

Solid Tumor

United States
University of Michigan
Cures Within Reach

Recruiting

Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO)

Retinitis Pigmentosa

United States
University Hospital, Montpellier

Terminated

Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial) (COVIDOC)

Coronavirus Infection | Pneumonia, Viral

France
Assistance Publique - Hôpitaux de Paris

Completed

Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus (PREP-COVID)

SARS-CoV-2 Infection

France
Hospital do Coracao
Hospital Israelita Albert Einstein; Hospital Sirio-Libanes; Brazilian Research... and other collaborators

Completed

Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19) (Coalition-I)

Coronavirus Infections

Brazil
Ravi Amaravadi, MD

Terminated

The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine) (PATCH)

COVID-19

United States
Brigham and Women's Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis (SAIL)

Lymphangioleiomyomatosis

United States
GeoSentinel Foundation

Unknown

HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial (HERO)

COVID-19 | Prophylaxis | Hydroxychloroquine | Health Care Worker

United States
University of the Philippines

Withdrawn

The University of the Philippines Hydroxychloroquine PEP Against COVID-19 Trial

COVID-19

Philippines
General and Teaching Hospital Celje

Unknown

Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia

Covid-19

Slovenia
National Institute of Allergy and Infectious Diseases...
Teva Pharmaceutical Industries, Ltd.

Terminated

Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19

COVID-19 | SARS-CoV 2

United States
Government of Punjab, Specialized Healthcare and...
Harvard School of Public Health (HSPH); Forman Christian College, Pakistan; Services... and other collaborators

Terminated

Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds (PEACE)

COVID-19 | Coronavirus Infection | SARS-CoV-2 | Asymptomatic Condition

Pakistan
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets

Immunosuppression | Rheumatism
Apsen Farmaceutica S.A.
Federal University of São Paulo

Withdrawn

Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)

Coronavirus Infections | SARS-CoV 2 | Pulmonary Disease | SARS (Severe Acute Respiratory Syndrome)

Brazil
Rutgers, The State University of New Jersey

Terminated

Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19

COVID-19 | SARS-CoV-2

United States
Government of Punjab, Specialized Healthcare and...
Services Hospital, Lahore; Mayo Hospital Lahore; Pakistan Kidney and Liver Institute

Terminated

PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds (PRECISE)

Covid-19 | Sars-CoV2 | Symptomatic Condition

Pakistan
Rutgers, The State University of New Jersey
National Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey

Completed

Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer

Prostate Cancer

United States
Vanderbilt University

Completed

Hydroxychloroquine in Cystic Fibrosis

Cystic Fibrosis

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey

Completed

Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery

Melanoma (Skin)

United States
University Hospital Center of Martinique

Completed

Lupus and Observance (LUPOBS)

Systemic Lupus, Skin Lupus

France
NYU Langone Health

Completed

COVID-19 PrEP HCW HCQ Study

COVID-19

United States
Assistance Publique - Hôpitaux de Paris

Withdrawn

Acute Rhabdomyolysis and Muscle Pain Associated With Mutations in the LPIN1 Gene - A Retrospective Study Describing the Safety and Efficacy of Hydroxychloroquine Sulfate Given on a Compassionate Basis to Patients Suffering From Lipin-1 Deficiency (LIPIN-1-METAB)

LIPIN1 Deficiency

France
University Hospital, Toulouse

Completed

Hydroxychloroquine in Giant Cell Arteritis

Giant Cell Arteritis

France
Assistance Publique - Hôpitaux de Paris
Sanofi-Synthelabo

Completed

The Reduction of Systemic Lupus Erythematosus Flares :Study PLUS

Systemic Lupus Erythematosus

France
Nanfang Hospital of Southern Medical University

Completed

Sequential Application of Yisaipu® and DMARDs in Treating Mild-to-Moderate AS

Ankylosing Spondylitis

China
Sanofi
Regeneron Pharmaceuticals

Completed

To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)

Rheumatoid Arthritis

Hungary, Portugal, Austria, United States, Argentina, Australia, Brazil, Canada, Czechia, Germany, Greece, Guatemala, Israel, Italy, Korea, Republic of, Lithuania, Mexico, New Zealand, Peru, Poland, Romania, Russian Federation, Spain, Taiwa... and more
University of Alabama at Birmingham
Pfizer; Amgen; Barr Laboratories

Completed

Treatment of Early Aggressive Rheumatoid Arthritis (TEAR) (TEAR)

Rheumatoid Arthritis

United States
Rigshospitalet, Denmark

Recruiting

Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss

Recurrent Pregnancy Loss

Denmark
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer

Breast Cancer

United States
Hackensack Meridian Health

Completed

Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers

Covid19

United States
Peking University First Hospital

Completed

A Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy

Hydroxychloroquine | IgA Patients

China
LLiu

Completed

Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy: a Self- Controlled Study

Primary IgA Nephropathy

China
University Medical Center Groningen

Completed

Local Tolerability and Pharmacokinetic Evaluation of Cyclops Dry Powder Hydroxychloroquine Inhalation in Healthy Volunteers

Covid19

Netherlands
Regional Center for Disease Control and Prevention...
Farhat Hached Hospital, Tunisia; Fattouma Bourguiba, Tunisia

Unknown

Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis (APCC-19)

SARS-CoV Infection
Ministry of Health and Population, Egypt

Unknown

Ivermectin In Treatment of COVID 19 Patients

Covid19

Egypt
University Hospital Tuebingen
Universitätsklinikum Hamburg-Eppendorf; Robert Bosch Medical Center; Bernhard...

Terminated

Hydroxychloroquine for COVID-19 (COV-HCQ)

COVID-19, Hydroxychloroquine Sulfate

Germany
Makerere University

Active, not recruiting

Hydroxychloroquine for Treatment of Non-Severe COVID-19 (HONEST)

Covid19

Uganda
Texas Cardiac Arrhythmia Research Foundation

Withdrawn

Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk (PREVENT)

COVID-19
Western Regional Medical Center

Terminated

Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy (ABC01)

Estrogen Receptor Positive Breast Cancer

United States
Hospices Civils de Lyon

Unknown

MEK and Autophagy Inhibition in Metastatic/Locally Advanced, Unresectable Neuroblastoma RAS (NRAS) Melanoma (CHLOROTRAMMEL)

Metastatic NRAS Melanoma

France

Search clinical trials for: Methotrexate, Hydroxychloroquine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations